18
Participants
Start Date
April 30, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
December 31, 2009
Obatoclax
A 3-hour IV infusion for 3 consecutive days or a 24-hour infusion for 3 consecutive days every 2 weeks for up to 6 cycles.
St. Vincent's Comprehensive Cancer Center, New York
Penn State Hershey Cancer Institute-Clinical Trials Office, Hershey
St. Joseph Mercy Hospital, Ann Arbor
University of Michigan Health System, Ann Arbor
Michigan State University - Breslin Cancer Center, Lansing
The University of Iowa, Iowa City
Northwestern University, Chicago
University of Kansas Medical Center Research Institute, Westwood
MD Anderson Cancer Center, Houston
Legacy Emanuel Hospital & Health Center, Portland
Benaroya Research Institute at Virginia Mason, Seattle
Dana Farber Cancer Institute, Boston
Princess Margaret Hospital, Toronto
Lead Sponsor
Gemin X
INDUSTRY